Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

FREELINE THERAPEUTICS HOLDINGS LIMITED

Company number 12546479

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
22 Jul 2020 SH02 Sub-division of shares on 28 June 2020
22 Jul 2020 SH02 Sub-division of shares on 28 June 2020
22 Jul 2020 SH02 Sub-division of shares on 28 June 2020
22 Jul 2020 SH02 Sub-division of shares on 28 June 2020
15 Jul 2020 MAR Re-registration of Memorandum and Articles
15 Jul 2020 CERT5 Certificate of re-registration from Private to Public Limited Company
15 Jul 2020 BS Balance Sheet
15 Jul 2020 AUDR Auditor's report
15 Jul 2020 AUDS Auditor's statement
15 Jul 2020 RESOLUTIONS Resolutions
  • RES02 ‐ Resolution of re-registration
15 Jul 2020 RR01 Re-registration from a private company to a public company
14 Jul 2020 SH19 Statement of capital on 14 July 2020
  • GBP 125,340.38169
14 Jul 2020 SH20 Statement by Directors
14 Jul 2020 CAP-SS Solvency Statement dated 06/07/20
14 Jul 2020 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share prem a/c 07/07/2020
  • RES06 ‐ Resolution of reduction in issued share capital
10 Jul 2020 AP01 Appointment of Theresa Marie Heggie as a director on 26 June 2020
09 Jul 2020 PSC05 Change of details for Syncona Limited as a person with significant control on 1 July 2020
09 Jul 2020 PSC07 Cessation of Benjamin Charles Warriner as a person with significant control on 27 June 2020
09 Jul 2020 PSC02 Notification of Syncona Limited as a person with significant control on 27 June 2020
09 Jul 2020 PSC07 Cessation of Brian Michael Silver as a person with significant control on 26 June 2020
09 Jul 2020 PSC01 Notification of Benjamin Charles Warriner as a person with significant control on 26 June 2020
08 Jul 2020 AA01 Current accounting period shortened from 30 April 2021 to 31 December 2020
08 Jul 2020 SH01 Statement of capital following an allotment of shares on 1 July 2020
  • GBP 123,639,300.15834
08 Jul 2020 SH01 Statement of capital following an allotment of shares on 27 June 2020
  • GBP 123,638,835
08 Jul 2020 AP01 Appointment of Jeffrey Allan Chodakewitz as a director on 26 June 2020